MECHANISMS AND BIOLOGICAL IMPACT OF DAPTOMYCIN RESISTANCE IN VRE
Grant number: 1185213 | Funding period: 2020 - 2023
Daptomycin is a last resort antibiotic used to treat vancomycin resistant Enterococcus faecium. If the use of daptomycin is lost due to widespread resistance, clinicians will be faced with the prospect of combatting a potentially untreatable hospital infection. This application will determine the prevalence of daptomycin resistance in Australia and define the mechanisms and consequences of this resistance. This knowledge will be critical for preserving this essential antibiotic.
Related publications (3)
Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract.
Noel P Pitcher, Jitendra R Harjani, Yichao Zhao, Jianwen Jin, Daniel R Knight, Lucy Li, Papanin Putsathit, Thomas V Riley, Glen P Carter, Jonathan B Baell
Colonization of the gastrointestinal (GI) tract with pathogenic bacteria is an important risk factor for the development of certai..
Daptomycin Resistance Occurs Predominantly in vanA-Type Vancomycin-Resistant Enterococcus faecium in Australasia and Is Associated With Heterogeneous and Novel Mutations
Lucy Li, Charlie Higgs, Adrianna M Turner, Yi Nong, Claire L Gorrie, Norelle L Sherry, Kristin H Dyet, Torsten Seemann, Deborah A Williamson, Timothy P Stinear, Benjamin P Howden, Glen P Carter
Healthcare associated infections caused by vancomycin-resistant Enterococcus faecium (VREfm) have a major impact on health outcome..
Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus
Adrianna M Turner, Jean YH Lee, Claire L Gorrie, Benjamin P Howden, Glen P Carter
Multidrug-resistant Staphylococcus and vancomycin-resistant Enterococcus (VRE) are important human pathogens that are resistant to..